Reldesemtiv

N/A

Report date: 2024/03/07 13:13:11
NME

Base Information

Drug NameReldesemtiv
Drug Alias NameCK-2127107CK-107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFast skeletal troponin complex activators
TargetsFast skeletal troponin complex
Therapy Area/IndicationsMobility LimitationMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytokinetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncAstellas Pharma Global Development IncCytokinetics Inc
Active IndicationsN/A
Inactive IndicationsMobility LimitationMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A